CXCR4 and acute myeloid leukemia: One approach has been to remove malignant hematopoietic cells from their supportive niche through mobilization of AML cells using the CXCR4 blocker plerixafor (as done to mobilize normal stem/progenitor cells for hematopoietic transplantation in conjunction with G-CSF).